| Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 CJL Murray, T Vos, R Lozano, M Naghavi, AD Flaxman, C Michaud, ... The lancet 380 (9859), 2197-2223, 2012 | 11295 | 2012 |
| Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 T Vos, AD Flaxman, M Naghavi, R Lozano, C Michaud, M Ezzati, ... The lancet 380 (9859), 2163-2196, 2012 | 10200 | 2012 |
| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic … MH Forouzanfar, A Afshin, LT Alexander, HR Anderson, ZA Bhutta, ... The lancet 388 (10053), 1659-1724, 2016 | 7917 | 2016 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic … T Vos, RM Barber, B Bell, A Bertozzi-Villa, S Biryukov, I Bolliger, ... The lancet 386 (9995), 743-800, 2015 | 7017 | 2015 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of … T Vos, C Allen, M Arora, RM Barber, ZA Bhutta, A Brown, A Carter, ... The lancet 388 (10053), 1545-1602, 2016 | 5987* | 2016 |
| Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of … S Abdalla, F Abd-Allah, MI Abdel Aziz The Lancet, 2015 | 5470 | 2015 |
| Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global … H Wang, M Naghavi, C Allen, RM Barber, ZA Bhutta, A Carter, DC Casey, ... The lancet 388 (10053), 1459-1544, 2016 | 4587 | 2016 |
| Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying … CJL Murray, RM Barber, KJ Foreman, AA Ozgoren, F Abd-Allah, SF Abera, ... The Lancet 386 (10009), 2145-2191, 2015 | 2346* | 2015 |
| Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 JA Salomon, T Vos, DR Hogan, M Gagnon, M Naghavi, A Mokdad, ... The Lancet 380 (9859), 2129-2143, 2012 | 1555 | 2012 |
| Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of … H Wang, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ... The Lancet 390 (10100), 1084-1150, 2017 | 873 | 2017 |
| Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease CR Scanzello, E Umoh, F Pessler, C Diaz-Torne, T Miles, E Dicarlo, ... Osteoarthritis and cartilage 17 (8), 1040-1048, 2009 | 304 | 2009 |
| High prevalence of ultrasonographic synovitis and enthesopathy in patients with psoriasis without psoriatic arthritis: a prospective case–control study E Naredo, I Möller, E de Miguel, E Batlle-Gualda, C Acebes, E Brito, ... Rheumatology 50 (10), 1838-1848, 2011 | 266 | 2011 |
| Epidemiology of gout: an update EUR Smith, C Diaz-Torne, F Perez-Ruiz, LM March Best Practice & Research Clinical Rheumatology 24 (6), 811-827, 2010 | 254 | 2010 |
| Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial. SSM Perez-Moreiras JV, Gomez-Reino JJ, Maneiro JR, Perez-Pampin E, Romo ... Am J Ophthalmol. 195, 181-190, 2018 | 235 | 2018 |
| Power Doppler ultrasonography assessment of entheses in spondyloarthropathies: response to therapy of entheseal abnormalities E Naredo, E Batlle-Gualda, ML García-Vivar, AM García-Aparicio, ... The Journal of rheumatology 37 (10), 2110-2117, 2010 | 174 | 2010 |
| Outcome domains for studies of acute and chronic gout HR Schumacher, W Taylor, L Edwards, R Grainger, N Schlesinger, ... The Journal of Rheumatology 36 (10), 2342-2345, 2009 | 151 | 2009 |
| Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA … S Castañeda, MA Martín-Martínez, C González-Juanatey, J Llorca, ... Seminars in arthritis and rheumatism 44 (6), 618-626, 2015 | 145 | 2015 |
| The synovitis of “non-inflammatory” orthopaedic arthropathies: a quantitative histological and immunohistochemical analysis F Pessler, L Dai, C Diaz-Torne, C Gomez-Vaquero, ME Paessler, ... Annals of the rheumatic diseases 67 (8), 1184-1187, 2008 | 141 | 2008 |
| La carga de enfermedad en España: resultados del Estudio de la Carga Global de las Enfermedades 2016 JB Soriano, D Rojas-Rueda, J Alonso, JM Antó, PJ Cardona, ... Medicina clinica 151 (5), 171-190, 2018 | 108 | 2018 |
| New medications in development for the treatment of hyperuricemia of gout C Diaz-Torné, N Perez-Herrero, F Perez-Ruiz Current opinion in rheumatology 27 (2), 164-169, 2015 | 102 | 2015 |
Dr. Hèctor CorominasAssociate ProfessorDirección de correo verificada de santpau.cat
